|
CSF-restricted OCB, all LPs
|
Pattern I
|
15/17 (88.2)
|
P < 0.00004
|
|
Patterns II + III
|
10/37 (27)
| |
|
Reiber et al. [19]
|
262/267 (98)
|
P < 0.000001
|
|
Patterns II + III
|
10/37 (27)
| |
|
Pattern I
|
15/17 (88.2)
|
P < 0.0001
|
|
Pattern II
|
9/25 (36)
| |
|
Pattern III
|
1/12 (8.3)
| |
|
CSF-restricted OCB, patients
|
Pattern I
|
8/10 (80)
|
P < 0.03
|
|
Patterns II + III
|
7/22 (31.8)
| |
|
Reiber et al. [19]
|
262/267 (98)
|
P < 0.000001
|
|
Patterns II + III
|
7/22 (31.8)
| |
|
CSF-restricted OCB, patients, w/o transient OCBs
|
Pattern I
|
8/10 (80)
|
P < 0.006
|
|
Patterns II + III
|
5/22 (22.7)
| |
|
Reiber et al. [19]
|
262/267 (98)
|
P < 0.00001
|
|
Patterns II + III
|
5/22 (22.7)
| |
|
MRZ reaction (≥2 AIs >1.5), all LPs
|
Jarius et al. [23]
|
397/546 (69)
|
P < 0.000001
|
|
Patterns II + III
|
0/12 (0)
| |
|
M and/or R and/or Z >1.5, all LPs
|
Reiber et al. [19]
|
158/177 (89)
|
P < 0.000001
|
|
Patterns II + III
|
0/12 (0)
| |
|
QIgG > Qlim(lgG), all LPs
|
Pattern I
|
7/17 (41.2)
|
P < 0.03
|
|
Patterns II + III
|
5/41 (12.2)
| |
|
QAlb > Qlim(Alb), all LPs
|
Pattern I
|
4/17 (23.5)
|
P < 0.002
|
|
Patterns II + III
|
30/43 (69.8)
| |
|
Pattern I
|
4/17 (23.5)
|
P = 0.002
|
|
Pattern II
|
16/26 (61.5)
| |
|
Pattern III
|
14/17 (82.4)
| |
|
QAlb, all LPs
|
Pattern I
|
4.81 (3.01–10.8; 17)
|
P < 0.005
|
|
Patterns II + III
|
8.39 (2.1–33.9; 42)
| |
|
Albumin CSF, all LPs
|
Pattern I
|
204 (95–517; 17)
|
P < 0.009
|
|
Patterns II + III
|
331 (81.2–726; 41)
| |
|
Total CSF protein elevated, all LPs
|
Pattern I
|
3/15 (20)
|
P < 0.003
|
|
Patterns II + III
|
29/43 (67.4)
| |
|
Total CSF protein, all LPs
|
Pattern I
|
375 (187–750; 15)
|
P < 0.007
|
|
Patterns II + III
|
550 (168–1930; 43)
| |
|
Albuminocytological dissociation, all LPs
|
Pattern I
|
1/8 (12.5)
|
P < 0.04
|
|
Patterns II + III
|
13/21 (61.9)
| |
